"Long-term Safety and Efficacy Study of Ferriprox® for the Treatment of Transfusional Iron Overload in Patients with Sickle Cell Disease or Other Anemias"

drug protocol number
LA38-EXT
drug sponsor
ApoPharma
drug study
Deferiprone
drug trial site
ACH
drug status
Ongoing
drug phase